Logo

drug discovery

Rezo Therapeutics Launches With $78M in Series A Funding

The firm will initially focus on developing a pipeline of biomarker-guides therapies for solid tumors.

Nucleome Therapeutics Closes £37.5M Series A Financing Round

The British firm will look to expand its atlas of the "dark genome" with 3D mapping to inform drug discovery.

Sophia Genetics Partners With MSK on Clinical Decision Support, Boundless Bio on ecDNA Detection

Sophia will provide Memorial Sloan Kettering with predictive tumor analysis technology and help startup Boundless develop new therapies and MDx methods.

With CellPhenomics Deal, Indivumed to Offer AI-Driven Drug Target Validation
Premium

A €4.3 million EU grant is supporting the German firms' work on AI technology to accelerate precision oncology.

Indivumed, CellPhenomics Partner on Cancer Drug Target Research

The two German companies will share tumor data for AI-based in silico target discovery and in vitro validation.

Aug 24, 2022

Mount Sinai Million Health Discoveries Program Represents New Ground for Partner Regeneron
Premium

Jun 30, 2022

MultiOmic Health, Mesh Bio Partner to Study Chronic Metabolic Disease for Drug, Dx Development

Jun 1, 2022

Startup Quantori Seeks to Accelerate Multiomic R&D for Pharma, Biotech, Hospitals
Premium

May 27, 2022

23andMe Counting on Lemonaid Health to Achieve Vision of Personalized Care
Premium

May 20, 2022

Tempus Takes on Precision Neuropsychiatry With New Research Dataset
Premium

May 17, 2022

Qiagen Expands Into Data Scientist Market With 'Biomedical Knowledge Base' Product
Premium

May 2, 2022

Rancho Biosciences Launches Single-Cell Data Science Consortium With Pharma Firms

Apr 27, 2022

Illumina, Janssen Biotech Form Strategic Partnership to Develop Precision Medicines

Apr 25, 2022

Zephyr AI Looks to Serve Drug Discovery, Value-Based Care Markets
Premium

Apr 13, 2022

Nurosene Health, Ontario Institute for Cancer Research Team for Pancreatic Cancer Research

Mar 22, 2022

Depixus Seeks to Commercialize 'Magnetic Tweezers' for Drug Discovery, Liquid Biopsy Research
Premium

Mar 1, 2022

Lifebit, Boehringer Ingelheim Collaborate on Data, Analytics for Drug Discovery

Feb 22, 2022

Sema4, BioSymetrics Partner on Multiomic Drug Discovery

Dec 9, 2021

Microsoft, M2Gen Collaborate on Oncology Analytics for Drug Discovery

Nov 22, 2021

Twist Bioscience Reports 17 Percent Growth of Fiscal Q4 Revenues, to Acquire Abveris

Jun 24, 2021

Indivumed Launches Bioinformatics Platform, Expands Cancer Drug Discovery Efforts
Premium

Apr 27, 2021

Syntegra Teams With Vanderbilt's Nashville Biosciences on Biobank Data Analysis for Drug R&D

Apr 19, 2021

ERS Genomics Licenses CRISPR Patents to Nuvisan

Mar 30, 2021

Enpicom, Viroclinics-DDL Expand Partnership to Accelerate Antibody, Vaccine Discovery

Mar 30, 2021

Cleveland Clinic, IBM Partner on High-Performance Computing for Life Science, Healthcare Research

Breaking News
The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.